Gene: DENND2D
Official Full Name: DENN domain containing 2Dprovided by HGNC
Gene Summary: Enables guanyl-nucleotide exchange factor activity. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18328 | DENND2D Knockout cell line (HeLa) | Human | DENND2D | 1:3~1:6 | Negative | Online Inquiry |
KO18329 | DENND2D Knockout cell line (HCT 116) | Human | DENND2D | 1:2~1:4 | Negative | Online Inquiry |
KO18330 | DENND2D Knockout cell line (A549) | Human | DENND2D | 1:3~1:4 | Negative | Online Inquiry |
DENND2D Gene Knockout Cell Lines are specialized cellular models engineered to lack the DENND2D gene, which encodes a protein involved in various cellular processes, including membrane trafficking and signal transduction. These knockout cell lines provide researchers with a powerful tool to elucidate the role of DENND2D in cellular functions and its potential implications in disease mechanisms.
The key function of DENND2D involves its interactions with Rab GTPases, playing a crucial role in endosome trafficking and subsequent signaling pathways. By utilizing these knockout lines, scientists can investigate the downstream effects of DENND2D loss on cellular processes such as autophagy, vesicle transport, and receptor recycling. This knowledge can significantly contribute to understanding diseases such as cancer and neurodegeneration, where membranous interactions are disrupted.
In academic and clinical research settings, DENND2D Gene Knockout Cell Lines offer significant advantages for investigating gene function and for high-throughput screening applications. They provide a controlled experimental milieu where the absence of DENND2D enables the study of compensatory mechanisms and the identification of potential therapeutic targets. Compared to conventional models, these knockout lines facilitate a clearer interpretation of data due to the absence of background expression of the target gene, offering enhanced specificity in experimental outcomes.
Researchers and clinicians will find value in these cell lines as they streamline the process of gene function studies while fostering the development of targeted therapies. With the emphasis on precision medicine and gene-based interventions, understanding the roles of genes like DENND2D in pathological states is more critical than ever.
Our company specializes in the development and provision of high-quality biological products, and our DENND2D Gene Knockout Cell Lines exemplify our commitment to supporting innovative research. By equipping scientists with reliable tools, we aim to drive forward the frontiers of medical and biological science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.